Literature DB >> 21683267

Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients.

Cinara C B Mattos1, Cristina S Meira, Ana I C Ferreira, Fábio B Frederico, Roberto M Hiramoto, Gildásio C Almeida, Luiz C Mattos, Vera L Pereira-Chioccola.   

Abstract

This prospective study evaluated the value of laboratorial diagnosis in ocular toxoplasmosis analyzing peripheral blood samples from a group of Brazilian patients by immunologic and molecular methods. We analyzed blood samples from 184 immunocompetent patients with ocular disorders divided into 2 groups: Group I, composed of samples from 49 patients with ocular toxoplasmosis diagnosed by clinical features; Group II, samples from 135 patients with other ocular diseases. Samples were assayed by conventional polymerase chain reaction (cnPCR), real-time PCR (qPCR) for Toxoplasma gondii, indirect immunofluorescence reaction (IF), avidity test (crude tachyzoite lysate as antigen), and excreted-secreted tachyzoite proteins as antigen (ESA-ELISA). cnPCR and qPCR profiles were concordant in all samples. Positive PCR was shown in 40.8% of group I patients. The majority of the positive blood samples (75%) were taken from patients with toxoplasmic retinochoroiditis scars, and the others (25%), from patients with retinal exudative lesions. Despite that 86 of the 135 patients from Group II had asymptomatic toxoplasmosis, all DNA blood samples had negative PCR. Concordant results were shown in the data obtained by serologic methods. Around 24% of the patients with ocular toxoplasmosis had high antibody titers determined by ESA-ELISA and IF. Anti-ESA antibodies are shown principally in patients with active infection. Collectively, these data demonstrate the presence of tachyzoites in the blood of patients with chronic infection, supporting the idea of recurrent disease. Circulating parasites in blood of immunocompetent individuals may be associated with the reactivation of the ocular disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683267     DOI: 10.1016/j.diagmicrobio.2011.02.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis.

Authors:  C Bourdin; A Busse; E Kouamou; F Touafek; B Bodaghi; P Le Hoang; D Mazier; L Paris; A Fekkar
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

2.  Genotype analysis of T. gondii strains associated with human infection in Egypt.

Authors:  Mona Mohamed Tolba; Hend Ali El-Taweel; Safia Saleh Khalil; Walaa Ali Hazzah; Mohamed Gamal Heshmat
Journal:  Parasitol Res       Date:  2014-02-14       Impact factor: 2.289

3.  Real-time PCR as a prognostic tool for human congenital toxoplasmosis.

Authors:  Júlia Gatti Ladeia Costa; Ana Carolina Aguiar Vasconcelos Carneiro; Alice Thomáz Tavares; Gláucia Manzan Queiroz Andrade; Daniel Vitor Vasconcelos-Santos; José Nélio Januário; Daniel Menezes-Souza; Ricardo Toshio Fujiwara; Ricardo Wagner Almeida Vitor
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

4.  Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.

Authors:  Cristina S Meira; Vera L Pereira-Chioccola; José E Vidal; Cinara C Brandão de Mattos; Gabriela Motoie; Thais A Costa-Silva; Ricardo Gava; Fábio B Frederico; Luiz C de Mattos
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

5.  Twenty-six circulating antigens and two novel diagnostic candidate molecules identified in the serum of canines with experimental acute toxoplasmosis.

Authors:  Junxin Xue; Wei Jiang; Yongjun Chen; Yingchun Liu; Huajing Zhang; Yan Xiao; Yuanbiao Qiao; Kehe Huang; Quan Wang
Journal:  Parasit Vectors       Date:  2016-06-29       Impact factor: 3.876

6.  Serum IgG Anti-Toxoplasma gondii Antibody Concentrations Do Not Correlate Nested PCR Results in Blood Donors.

Authors:  Fabiana Nakashima; Valquíria Sousa Pardo; Marcos Paulo Miola; Fernando Henrique Antunes Murata; Natalia Paduan; Stefani Miqueline Longo; Cinara Cássia Brandão de Mattos; Vera Lucia Pereira-Chioccola; Octávio Ricci; Luiz Carlos de Mattos
Journal:  Front Cell Infect Microbiol       Date:  2020-01-14       Impact factor: 5.293

7.  Risk factors for ocular toxoplasmosis in Brazil.

Authors:  A I C Ferreira; C C Brandão De Mattos; F B Frederico; C S Meira; G C Almeida; F Nakashima; C R Bernardo; V L Pereira-Chioccola; L C De Mattos
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 4.434

8.  A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis.

Authors:  Mariana Previato; Fábio Batista Frederico; Fernando Henrique Antunes Murata; Rubens Camargo Siqueira; Amanda Pires Barbosa; Aparecida Perpétuo Silveira-Carvalho; Cristina da Silva Meira; Vera Lúcia Pereira-Chioccola; Ricardo Gava; Plínio Pereira Martins Neto; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2015-12-07

9.  Evaluation of Serological and Molecular Tests Used for the Identification of Toxoplasma gondii Infection in Patients Treated in an Ophthalmology Clinic of a Public Health Service in São Paulo State, Brazil.

Authors:  Fernando Henrique Antunes Murata; Mariana Previato; Fábio Batista Frederico; Amanda Pires Barbosa; Fabiana Nakashima; Geraldo Magela de Faria; Aparecida Perpétuo Silveira Carvalho; Cristina da Silva Meira Strejevitch; Vera Lucia Pereira-Chioccola; Lilian Castiglioni; Luiz Carlos de Mattos; Rubens Camargo Siqueira; Cinara Cássia Brandão de Mattos
Journal:  Front Cell Infect Microbiol       Date:  2020-02-07       Impact factor: 5.293

10.  Molecular diagnosis of symptomatic toxoplasmosis: a 9-year retrospective and prospective study in a referral laboratory in São Paulo, Brazil.

Authors:  Lilian Muniz Camilo; Vera Lucia Pereira-Chioccola; Ricardo Gava; Cristina da Silva Meira-Strejevitch; Jose Ernesto Vidal; Cinara Cássia Brandão de Mattos; Fábio Batista Frederico; Luiz Carlos De Mattos; Lígia Cosentino Junqueira Franco Spegiorin
Journal:  Braz J Infect Dis       Date:  2017-09-29       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.